Medication Adherence and FDA: A Q&A With Safe Use Head
This article was originally published in RPM Report
Executive Summary
One of the many stakeholders involved with the National Consumers League’s adherence campaign is FDA, through CDER’s Safe Use Initiative, CDER’s Office of Communication and FDA’s Office of Women’s Health. Here is an email Q&A with Safe Use Initiative Director Karen Weiss for more details on FDA’s role in Script Your Future and medication adherence more broadly.